share_log

Key Takeaways From Gritstone Bio Analyst Ratings

Key Takeaways From Gritstone Bio Analyst Ratings

Gritstone Bio分析師評級要點
Benzinga ·  10/01 16:01  · 評級/大行評級

Across the recent three months, 4 analysts have shared their insights on Gritstone Bio (NASDAQ:GRTS), expressing a variety of opinions spanning from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings21100
Last 30D00100
1M Ago00000
2M Ago21000
3M Ago00000

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $3.38, a high estimate of $5.00, and a low estimate of $0.50. Observing a downward trend, the current average is 20.47% lower than the prior average price target of $4.25.

1727812861_0.png

Decoding Analyst Ratings: A Detailed Look

The analysis of...

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論